| (210) | Number of the EPO application | 19749938 |
| (220) | Filing date of the EPO application | 2019.07.22 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2024, 2024.09.11 |
| (110) | EPO patent number | 3826662 |
| (21) | Number of the application | e 2021 0497 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | ALSINA-FERNANDEZ Jorge, US;
CABRERA Over, US;
COSKUN Tamer, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/26 (2006.01.01); A61P 3/10 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.06.30 |
| (30) | Priority | 201862702180 P, 2018.07.23, US; 201862730562 P, 2018.09.13, US; 201862740640 P, 2018.10.03, US |
| (86) | International application | PCT/US2019/042824, 2019.07.22 |
| (87) | International publication | WO 2020/023388, 2020.01.30 |